Our Products

A mother joyfully holding her daughter, both smiling against a cloudy sky.

While the science grounds us, our work is fueled by our passion for patients, a core value Syndax leads with and a conviction that runs deep throughout our organization.

FDA-Approved Medications

Patients & Care Partners

Revuforj.com

Healthcare Providers

RevuforjHCP.com

U.S. Prescribing Information Including Patient Information

Download PDF

Please see Full Prescribing Information, including BOXED WARNING here.

To report an adverse event or product quality complaint for Revuforj^® (revumenib), or to request additional medical information, contact medinfo@syndax.com or call 1-888-539-3REV (3738), option 1

SyndAccess™ Patient Support Program*

Talk with your Healthcare Team to learn more about program enrollment. Visit SYNDACCESS.COM or call us to learn more: 1-888-567-SYND (7963) Monday – Friday, 9AM-6PM ET.

SyndAccess

Healthcare Providers

Niktimvohcp.com

U.S. Prescribing Information Including Patient Information

View Here

Please see Full Prescribing Information for Niktimvo™ here.

You may report side effects for Niktimvo™ (axatilimab-csfr) to FDA at 1-800-FDA-1088. You may also report side effects to Incyte Corporation at 1-855-463-3463.

IncyteCARES

Incyte and Syndax are committed to supporting patients and minimizing barriers to ensure access to Niktimvo. Eligible patients in the U.S. and Puerto Rico who are prescribed Niktimvo can enroll into IncyteCARES for assistance. IncyteCARES may provide support and resources that help patients start and stay on therapy. More information about IncyteCARES is available by visiting incyteCARES.com or calling 1-855-452-5234, Monday through Friday, 8 AM–8 PM ET.